Trial Profile
Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2006
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 19 Sep 2006 New trial record.